Europe Veterinary Antibiotics Market Size, Share & Trends Report

Europe Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Animal Type (Cattle, Poultry), By Drug Class (Macrolides, Penicillins), By Dosage Form (Oral Solution, Oral Powder), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-988-4
  • Number of Report Pages: 180
  • Format: PDF, Horizon Databook
  • Historical Range: 2017 - 2020
  • Forecast Period: 2022 - 2030 
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology And Scope
                   1.1 Market Segmentation And Scope
                       1.1.1 Segment Scope
                       1.1.2 Country Scope
                       1.1.3 Estimates And Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database:
                       1.3.2 Gvr’s Internal Database
                       1.3.3 Secondary Sources
                       1.3.4 Primary Research
                       1.3.5 Details Of Primary Research
                   1.4 Information/Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                   1.7 List Of Secondary Sources
Chapter 2 Executive Summary
                   2.1 Europe Veterinary Antibiotics Market Outlook
                       2.1.1 Segment Outlook
                       2.1.2 Country Outlook
                       2.1.3 Competitive Outlook
                   2.2 Europe Veterinary Antibiotics Market Snapshot, 2021
                   2.3 Overall Estimated Sales Of Antimicrobial Vmps (Active Substance) In Tonnes By Country, In 2019/2020
                   2.4 Estimated Sales Of Antimicrobial Active Substances By Antimicrobial Class, 2019/2020
Chapter 3 Europe Veterinary Antibiotics Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent Market Analysis
                       3.1.2 Ancillary Market Analysis
                   3.2 Penetration And Growth Prospect Mapping
                   3.3 Europe Veterinary Antibiotics Market Dynamics
                       3.3.1 Market Driver Analysis
                           3.3.1.1 Rising Focus On Animal-Only Antibiotics And Ionophores
                           3.3.1.2 Growing Initiatives By Key Companies Or Launch Of New Products
                           3.3.1.3 Prudent And Responsible Use Of Antibiotics
                       3.3.2 Market Restraint Analysis
                           3.3.2.1 Stringent Regulations
                           3.3.2.2 Decline In Use Of Antibiotics
                           3.3.2.3 Active Research On Antibiotic Alternatives
                       3.3.3 Market Opportunity Analysis
                       3.3.4 Market Challenge Analysis
                   3.4 Industry Analysis
                       3.4.1 Porter’s Analysis
                           3.4.1.1 Supplier Power
                           3.4.1.2 Buyer Power
                           3.4.1.3 Threat Of Substitutes
                           3.4.1.4 Threat Of New Entrants
                           3.4.1.5 Competitive Rivalry
                       3.4.2 Pestel Analysis
                           3.4.2.1 Political & Legal Landscape
                           3.4.2.2 Economic & Social Landscape
                           3.4.2.3 Environmental Landscape
                           3.4.2.4 Technology Landscape
                   3.5 Regulatory Framework
                       3.5.1 Dossier Requirements
                   3.6 Patent-Off Dates Analysis For Major Veterinary Antibiotics
                   3.7 Product Pipeline Analysis
                   3.8 COVID-19 Impact Analysis
                       3.8.1 Current And Future Impact Analysis
                       3.8.2 Impact On Market Players
Chapter 4 Animal Type Estimates & Trend Analysis, 2017 - 2030 (USD Million)
                   4.1 Animal Type Movement Analysis, 2017 - 2030 (USD Million)
                   4.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
                   4.3 Pigs
                       4.3.1 Pigs Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   4.4 Cattle
                       4.4.1 Cattle Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   4.5 Sheep & Goats
                       4.5.1 Sheep & Goats Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   4.6 Poultry
                       4.6.1 Poultry Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   4.7 Others
                       4.7.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 5 Drug Class Estimates & Trend Analysis, 2017 - 2030 (USD Million)
                   5.1 Drug Class Movement Analysis, 2017 - 2030 (USD Million)
                   5.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
                       5.2.1 Tetracyclines
                           5.2.1.1 Tetracyclines Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.2 Penicillins
                           5.2.2.1 Penicillins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.3 Sulfonamides
                           5.2.3.1 Sulfonamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.4 Macrolides
                           5.2.4.1 Macrolides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.5 Trimethoprim
                           5.2.5.1 Trimethoprim Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.6 Lincosamides
                           5.2.6.1 Lincosamides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.7 Polymyxins
                           5.2.7.1 Polymyxins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.8 Aminoglycosides
                           5.2.8.1 Aminoglycosides Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.9 Fluoroquinolones
                           5.2.9.1 Fluoroquinolones Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.10 Pleuromutilins
                           5.2.10.1 Pleuromutilins Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       5.2.11 Others
                           5.2.11.1 Others market estimates and forecasts, 2017 - 2030 (USD Million)
Chapter 6 Dosage Form Estimates & Trend Analysis, 2017 - 2030 (USD Million)
                   6.1 Dosage Form Movement Analysis, 2017 - 2030 (USD Million)
                   6.2 Europe Veterinary Antibiotics Market Share Analysis, 2021 & 2030
                       6.2.1 Oral Powder
                           6.2.1.1 Oral Powder Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       6.2.2 Oral Solutions
                           6.2.2.1 Oral Solutions Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       6.2.3 Injections
                           6.2.3.1 Injection Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                       6.2.4 Others
                           6.2.4.1 Others Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 7 European Countries Estimates & Trend Analysis, 2017 - 2030 (USD Million)
                   7.1 European Countries Market Share Analysis, 2021 & 2030
                   7.2 Europe
                       7.2.1 Europe Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.3 Germany
                       7.3.1 Germany Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.4 U.K.
                       7.4.1 U.K. Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.5 France
                       7.5.1 France Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.6 Italy
                       7.6.1 Italy Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.7 Spain
                       7.7.1 Spain Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.8 Belgium
                       7.8.1 Belgium Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.9 The Netherlands
                       7.9.1 The Netherlands Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.10 Hungary
                       7.10.1 Hungary Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.11 Poland
                       7.11.1 Poland Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.12 Portugal
                       7.12.1 Portugal Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.13 Romania
                       7.13.1 Romania Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
                   7.14 Denmark
                       7.14.1 Denmark Veterinary Antibiotics Market Estimates And Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Europe Veterinary Antibiotics Market - Competitive Landscape
                   8.1 Company Profiles
                       8.1.1 MERCK & CO., INC.
                           8.1.1.1 Company overview
                           8.1.1.2 Financial performance
                           8.1.1.3 Product benchmarking
                           8.1.1.4 Strategic initiatives
                       8.1.2 CEVA
                           8.1.2.1 Company overview
                           8.1.2.2 Financial performance
                           8.1.2.3 Product benchmarking
                           8.1.2.4 Strategic initiatives
                       8.1.3 VETOQUINOL S.A.
                           8.1.3.1 Company overview
                           8.1.3.2 FINANCIAL PERFORMANCE
                           8.1.3.3 Product benchmarking
                           8.1.3.4 Strategic initiatives
                       8.1.4 ZOETIS
                           8.1.4.1 Company overview
                           8.1.4.2 Financial performance
                           8.1.4.3 Product benchmarking
                           8.1.4.4 Strategic initiatives
                       8.1.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
                           8.1.5.1 Company overview
                           8.1.5.2 Financial performance
                           8.1.5.3 Product benchmarking
                           8.1.5.4 Strategic initiatives
                       8.1.6 ELANCO
                           8.1.6.1 Company overview
                           8.1.6.2 Financial performance
                           8.1.6.3 Product benchmarking
                           8.1.6.4 Strategic initiatives
                       8.1.7 VIRBAC
                           8.1.7.1 Company overview
                           8.1.7.2 Financial Performance
                           8.1.7.3 Product benchmarking
                           8.1.7.4 Strategic initiatives
                       8.1.8 CALIER
                           8.1.8.1 Company overview
                           8.1.8.2 Financial performance
                           8.1.8.3 Product benchmarking
                           8.1.8.4 Strategic initiatives
                       8.1.9 BIMEDA, INC.
                           8.1.9.1 Company overview
                           8.1.9.2 Financial performance
                           8.1.9.3 Product benchmarking
                           8.1.9.4 Strategic initiatives
                       8.1.10 PRODIVET PHARMACEUTICALS SA/NV
                           8.1.10.1 Company overview
                           8.1.10.2 Product benchmarking
                   8.2 Market Participation Categorization
                   8.3 Company Market Position Analysis - Heat Map Analysis
                   8.4 Synergy Analysis: Major Deals & Strategic Alliances
                   8.5 List of Key Companies
                       8.5.1 List Of Manufacturers
                       8.5.2 List Of Distributors


List of Tables

Table. 1 List of secondary sources
Table. 2 Estimated sales of antimicrobial VMPs (active substance) in tonnes by country, in 2019/2020
Table. 3 Estimated sales of antimicrobial active substances by class, in 31 EU countries, 2019/2020 (tablets excluded)
Table. 4 Estimated sales of antimicrobial active substances by major class, in 31 EU countries, 2020 (only tablets)
Table. 5 EMA antibiotic class categorization for prudent and responsible use
Table. 6 Dossier submission for procedures involving veterinary NAPs to national competent authorities
Table. 7 Zoetis patent-off dates analysis for key veterinary antibiotics
Table. 8 Dechra Pharmaceuticals product pipeline analysis
Table. 9 Norbrook product pipeline analysis
Table. 10 List of Manufacturers
Table. 11 List of Distributors
Table. 12 Europe Veterinary Antibiotics market, by country, 2017 - 2030 (USD Million)
Table. 13 Europe Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 14 Europe Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 15 Europe Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 16 U.K. Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 17 U.K. Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 18 U.K. Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 19 Germany Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 20 Germany Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 21 Germany Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 22 France Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 23 France Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 24 France Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 25 Italy Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 26 Italy Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 27 Italy Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 28 Spain Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 29 Spain Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 30 Spain Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 31 The Netherlands Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 32 The Netherlands Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 33 The Netherlands Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 34 Belgium Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 35 Belgium Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 36 Belgium Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 37 Denmark Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 38 Denmark Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 39 Denmark Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 40 Hungary Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 41 Hungary Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 42 Hungary Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 43 Poland Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 44 Poland Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 45 Poland Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 46 Portugal Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 47 Portugal Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 48 Portugal Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)
Table. 49 Romania Veterinary Antibiotics market, by Animal Type, 2017 - 2030 (USD Million)
Table. 50 Romania Veterinary Antibiotics market, by Drug Class, 2017 - 2030 (USD Million)
Table. 51 Romania Veterinary Antibiotics market, by Dosage Form, 2017 - 2030 (USD Million)


List of Figures

Fig. 1 Europe Veterinary Antibiotics market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 General methodology for Commodity flow analysis of Animal Health markets
Fig. 9 Commodity flow analysis
Fig. 10 Europe Veterinary Antibiotics Market Snapshot (2021, USD Million)
Fig. 11 Parent market outlook
Fig. 12 Ancillary market outlook
Fig. 13 Penetration & growth prospect mapping, by dosage form, 2021
Fig. 14 Europe Veterinary Antibiotics market dynamics analysis
Fig. 15 Europe Veterinary Antibiotics market driver analysis
Fig. 16 Europe Veterinary Antibiotics market restraint impact
Fig. 17 Europe veterinary antibiotics market: Animal type movement analysis, 2017 - 2030 (USD Million)
Fig. 18 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 19 Pigs market, 2017 - 2030 (USD Million)
Fig. 20 Cattle market, 2017 - 2030 (USD Million)
Fig. 21 Sheep & goats market, 2017 - 2030 (USD Million)
Fig. 22 Poultry market, 2017 - 2030 (USD Million)
Fig. 23 Other Animal Types market, 2017 - 2030 (USD Million)
Fig. 24 Europe veterinary antibiotics market: Drug class movement analysis, 2017 - 2030 (USD Million)
Fig. 25 Sales of antimicrobial active substances by class, %, 2020
Fig. 26 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 27 Tetracyclines market, 2017 - 2030 (USD Million)
Fig. 28 Penicillins market, 2017 - 2030 (USD Million)
Fig. 29 Sulfonamides market, 2017 - 2030 (USD Million)
Fig. 30 Macrolides market, 2017 - 2030 (USD Million)
Fig. 31 Trimethoprim market, 2017 - 2030 (USD Million)
Fig. 32 Lincosamides market, 2017 - 2030 (USD Million)
Fig. 33 Polymyxins market, 2017 - 2030 (USD Million)
Fig. 34 Aminoglycosides market, 2017 - 2030 (USD Million)
Fig. 35 Fluoroquinolones market, 2017 - 2030 (USD Million)
Fig. 36 Pleuromutilins market, 2017 - 2030 (USD Million)
Fig. 37 Other Drug Class market, 2017 - 2030 (USD Million)
Fig. 38 Europe veterinary antibiotics market: Dosage form movement analysis, 2017 - 2030 (USD Million)
Fig. 39 Sales of antimicrobial active substances by dosage form, %, 2020
Fig. 40 Europe veterinary antibiotics market share analysis, 2021 & 2030
Fig. 41 Oral powder market, 2017 - 2030 (USD Million)
Fig. 42 Oral solutions market, 2017 - 2030 (USD Million)
Fig. 43 Injection market, 2017 - 2030 (USD Million)
Fig. 44 Other Dosage Forms market, 2017 - 2030 (USD Million)
Fig. 45 European countries market share analysis, 2021 & 2030
Fig. 46 Europe veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 47 Germany veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 48 U.K. veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 49 France veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 50 Italy veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 51 Spain veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 52 Belgium veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 53 The Netherlands veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 54 Hungary veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 55 Poland veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 56 Portugal veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 57 Romania veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 58 Denmark veterinary antibiotics market, 2017 - 2030 (USD Million)
Fig. 59 Market participation categorization
Fig. 60 Company market position analysis
Fig. 61 Major deals & strategic alliances analysis

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon